C. Milstein

5.9k total citations · 2 hit papers
65 papers, 5.1k citations indexed

About

C. Milstein is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, C. Milstein has authored 65 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 33 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Immunology. Recurrent topics in C. Milstein's work include Monoclonal and Polyclonal Antibodies Research (33 papers), Glycosylation and Glycoproteins Research (17 papers) and T-cell and B-cell Immunology (8 papers). C. Milstein is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (33 papers), Glycosylation and Glycoproteins Research (17 papers) and T-cell and B-cell Immunology (8 papers). C. Milstein collaborates with scholars based in United Kingdom, Slovakia and Italy. C. Milstein's co-authors include G. Galfré, John V. Kilmartin, B Wright, Michael S. Neuberger, Cristina Rada, A. Claudio Cuello, M.R. Suresh, Michael R. Ehrenstein, John M. Jarvis and Jisnuson Svasti and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

C. Milstein

65 papers receiving 4.7k citations

Hit Papers

[1] Preparation of monoclonal antibodies: Strategies and ... 1981 2026 1996 2011 1981 1982 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Milstein United Kingdom 31 2.9k 1.7k 1.3k 738 365 65 5.1k
Ikuo Yamashina Japan 37 3.6k 1.2× 700 0.4× 1.6k 1.2× 1.0k 1.4× 339 0.9× 179 5.4k
Toshiaki Osawa Japan 39 4.2k 1.4× 620 0.4× 2.1k 1.6× 478 0.6× 242 0.7× 237 5.8k
Anthony L. Tarentino United States 38 5.1k 1.7× 671 0.4× 864 0.6× 815 1.1× 445 1.2× 70 6.8k
Donald Dowbenko United States 34 3.1k 1.1× 745 0.4× 1.4k 1.1× 815 1.1× 728 2.0× 50 5.5k
M. D. Poulik United States 30 2.2k 0.7× 643 0.4× 1.1k 0.8× 635 0.9× 315 0.9× 95 5.4k
Thomas H. Plummer United States 40 4.4k 1.5× 565 0.3× 729 0.5× 699 0.9× 709 1.9× 76 5.9k
Randolph Wall United States 41 4.6k 1.6× 830 0.5× 2.0k 1.5× 354 0.5× 783 2.1× 97 7.3k
R. Cortese Italy 49 4.5k 1.5× 791 0.5× 794 0.6× 571 0.8× 699 1.9× 86 6.5k
Åke Engström Sweden 47 4.8k 1.6× 961 0.6× 2.4k 1.8× 442 0.6× 501 1.4× 112 8.7k
David C. Benjamin United States 35 1.7k 0.6× 958 0.6× 1.5k 1.1× 292 0.4× 601 1.6× 106 4.3k

Countries citing papers authored by C. Milstein

Since Specialization
Citations

This map shows the geographic impact of C. Milstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Milstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Milstein more than expected).

Fields of papers citing papers by C. Milstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Milstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Milstein. The network helps show where C. Milstein may publish in the future.

Co-authorship network of co-authors of C. Milstein

This figure shows the co-authorship network connecting the top 25 collaborators of C. Milstein. A scholar is included among the top collaborators of C. Milstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Milstein. C. Milstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rada, Cristina, Michael R. Ehrenstein, Michael S. Neuberger, & C. Milstein. (1998). Hot Spot Focusing of Somatic Hypermutation in MSH2-Deficient Mice Suggests Two Stages of Mutational Targeting. Immunity. 9(1). 135–141. 301 indexed citations
2.
Milstein, C. & Michael S. Neuberger. (1996). Maturation of the Immune Response. Advances in protein chemistry. 49. 451–485. 32 indexed citations
3.
Aoufouchi, Saïd, José Yélamos, & C. Milstein. (1996). Nonsense Mutations Inhibit RNA Splicing in a Cell-Free System: Recognition of Mutant Codon Is Independent of Protein Synthesis. Cell. 85(3). 415–422. 121 indexed citations
4.
Rada, Cristina, África González‐Fernández, John M. Jarvis, & C. Milstein. (1994). The 5′ boundary of somatic hypermutation in a Vχ gene is in the leader intron. European Journal of Immunology. 24(6). 1453–1457. 79 indexed citations
5.
Lozano, Francisco, Cristina Rada, John M. Jarvis, & C. Milstein. (1993). Affinity maturation leads to differential expression of multiple copies of a κ light-chain transgene. Nature. 363(6426). 271–273. 35 indexed citations
6.
Sharpe, Melissa J., C. Milstein, John M. Jarvis, & Michael S. Neuberger. (1991). Somatic hypermutation of immunoglobulin kappa may depend on sequences 3′ of C kappa and occurs on passenger transgenes.. The EMBO Journal. 10(8). 2139–2145. 109 indexed citations
7.
Milstein, C., et al.. (1991). The identification of the β2‐microglobulin binding antigen encoded by the human CDID gene. European Journal of Immunology. 21(1). 71–78. 41 indexed citations
8.
Neuberger, Michael S., et al.. (1990). Lack of somatic mutation in a χ light chain transgene. European Journal of Immunology. 20(6). 1379–1385. 33 indexed citations
9.
Suresh, M.R., A. Claudio Cuello, & C. Milstein. (1986). [17] Bispecific monoclonal antibodies from hybrid hybridomas. Methods in enzymology on CD-ROM/Methods in enzymology. 121. 210–228. 126 indexed citations
10.
Milstein, C., Jos Even, & Claudia Berek. (1986). Molecular events during the onset and maturation of the antibody response.. PubMed. 51. 173–82. 5 indexed citations
11.
Milstein, C., et al.. (1984). Junctional diversity is essential to antibody activity.. The Journal of Immunology. 133(3). 1090–1092. 55 indexed citations
12.
Kaartinen, Maija, Gillian M. Griffiths, Pamela Hamlyn, et al.. (1983). Anti-oxazolone hybridomas and the structure of the oxazolone idiotype.. The Journal of Immunology. 130(2). 937–945. 103 indexed citations
13.
Galfré, G. & C. Milstein. (1981). [1] Preparation of monoclonal antibodies: Strategies and procedures. Methods in enzymology on CD-ROM/Methods in enzymology. 73(Pt B). 3–46. 1562 indexed citations breakdown →
14.
Voak, D., Steven H. Sacks, T. Reid Alderson, et al.. (1980). Monoclonal Anti‐A from a Hybrid‐Myeloma: Evaluation as a Blood Grouping Reagent. Vox Sanguinis. 39(3). 134–140. 76 indexed citations
15.
Lachmann, P J, et al.. (1980). Three rat monoclonal antibodies to human C3.. PubMed. 41(3). 503–15. 86 indexed citations
16.
Milstein, C.. (1969). The basic sequences of immunoglobulin κ chains: Sequence studies of bence jones proteins Rad, Fr 4 and B6. FEBS Letters. 2(5). 301–304. 22 indexed citations
17.
Milstein, Celia P. & C. Milstein. (1968). A tryptic peptide containing a unique serine phosphate residue in rabbit phosphoglucomutase. Biochemical Journal. 109(1). 93–99. 14 indexed citations
18.
Milstein, C.. (1966). Amino Acid Sequence in the Active Site of Phosphoglucomutase from Rabbit Muscle. Biochemical Journal. 100(3). 40C–42C. 3 indexed citations
19.
Milstein, C.. (1961). On the mechanism of activation of phosphoglucomutase by metal ions. Biochemical Journal. 79(3). 574–584. 46 indexed citations
20.
Milstein, C. & Frederick Sanger. (1961). An amino acid sequence in the active centre of phosphoglucomutase. Biochemical Journal. 79(3). 456–469. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026